购物车
- 全部删除
- 您的购物车当前为空
TPI-1020是一种新型的抗炎皮质类固醇和一氧化氮(NO)供体,源自布地奈德。TPI-1020表现出浓度依赖的支气管扩张作用,该作用通过释放的NO通过cGMP依赖途径介导。研究表明,TPI-1020将皮质类固醇和释放NO的活性结合起来,在治疗哮喘急性支气管收缩事件中可能具有益处,并可能减少吸入性beta(2)-肾上腺受体激动剂的所需剂量。
TPI-1020是一种新型的抗炎皮质类固醇和一氧化氮(NO)供体,源自布地奈德。TPI-1020表现出浓度依赖的支气管扩张作用,该作用通过释放的NO通过cGMP依赖途径介导。研究表明,TPI-1020将皮质类固醇和释放NO的活性结合起来,在治疗哮喘急性支气管收缩事件中可能具有益处,并可能减少吸入性beta(2)-肾上腺受体激动剂的所需剂量。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | TPI-1020 is a novel anti-inflammatory corticosteroid and nitric oxide (NO) donor derived from budesonide. It exhibits a concentration-dependent bronchodilatory effect mediated by released NO through a cGMP-dependent pathway. Studies suggest that TPI-1020 combines corticosteroid activity with NO release, potentially benefiting the treatment of acute bronchoconstriction events in asthma and allowing for a reduced dose of inhaled beta(2)-adrenoceptor agonists. |
别名 | TPI1020, TPI 1020, NCX-1020, NCX 1020 |
分子量 | 609.66 |
分子式 | C33H39NO10 |
CAS No. | 571186-52-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容